Lastacaft Once Daily Relief delivers prescription-strength ocular antihistamine therapy through 0.25% alcaftadine formulation, providing rapid symptom resolution for allergic conjunctivitis within 2 minutes of instillation. The once-daily dosing regimen achieves sustained 24-hour therapeutic coverage, minimizing histamine-mediated pruritus and ocular irritation triggered by environmental allergens including pollen, animal dander, and ragweed exposure. The twin-pack configuration (two 5 mL bottles) optimizes convenience for home and portable use, ensuring consistent medication availability across varied environments. Alcaftadine's selective H1-receptor antagonism provides targeted relief without systemic absorption, reducing adverse effects associated with oral antihistamines. This formulation represents an evidence-based therapeutic option for patients requiring sustained ocular allergy management with simplified dosing compliance and extended symptom control duration.
Lastacaft Once Daily Relief delivers prescription-strength ocular antihistamine therapy through 0.25% alcaftadine formulation, providing rapid symptom resolution for allergic conjunctivitis within 2 minutes of instillation. The once-daily dosing regimen achieves sustained 24-hour therapeutic coverage, minimizing histamine-mediated pruritus and ocular irritation triggered by environmental allergens including pollen, animal dander, and ragweed exposure. The twin-pack configuration (two 5 mL bottles) optimizes convenience for home and portable use, ensuring consistent medication availability across varied environments. Alcaftadine's selective H1-receptor antagonism provides targeted relief without systemic absorption, reducing adverse effects associated with oral antihistamines. This formulation represents an evidence-based therapeutic option for patients requiring sustained ocular allergy management with simplified dosing compliance and extended symptom control duration.